Related Experiment Videos
[Enalapril versus captopril in heart failure--effect on blood pressure and kidney function]
1Innere Medizin III (Schwerpunkt Kardiologie, Angiologie und Pulmologie), Medizinische Universitätsklinik Heidelberg.
Insights
This study found that both captopril and enalapril effectively lowered 24-hour blood pressure in heart failure patients. Neither angiotensin-converting enzyme inhibitor significantly affected heart rate during treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart failure management often involves angiotensin-converting enzyme inhibitors (ACEIs).
- Understanding the comparative effects of different ACEIs on blood pressure is crucial for patient care.
Purpose of the Study:
- To compare the 24-hour blood pressure effects of captopril and enalapril in patients with heart failure.
- To assess the impact of these ACEIs on serum electrolytes, creatinine, and plasma renin activity.
Main Methods:
- 33 patients with heart failure (NYHA II-III) were randomized to receive either captopril or enalapril.
- 24-hour ambulatory blood pressure monitoring was performed before and during ACEI therapy.
- Serum electrolytes, creatinine, and plasma renin activity were measured at baseline and during treatment.
Main Results:
- Both captopril and enalapril significantly reduced 24-hour systolic and diastolic blood pressure by day 5.
- The initial blood pressure lowering effect was comparable between the two ACEIs.
- Neither ACEI significantly altered heart rate or showed significant differences in their effects on blood pressure and heart rate profiles between groups.
Conclusions:
- Captopril and enalapril demonstrate similar efficacy in reducing 24-hour blood pressure in heart failure patients.
- These ACEIs do not significantly impact heart rate in this patient population.
- Further research may explore long-term effects and other cardiovascular parameters.
Abstract:
In 33 patients with heart failure (NYHA II-III) the 24-h blood pressure was examined during the titration of two ACE-inhibitors. Blood pressure was measured by the oscillometric method using the blood pressure monitor 90202 from SpaceLabs, Inc.. All patients received an additional therapy either with captopril (group A, n = 17) or enalapril (group B, n = 16) in random order. Serum-electrolytes, serum- and urine-creatinine, and plasma-renin- activity were measured before and during therapy with both ACE-inhibitors. 24-h blood pressure measurements were taken before and on the first and fifth days of the treatment with ACE-inhibitors. Neither group was different with respect to the degree of heart failure, the concomitant medication, and the 24-h profiles of blood pressure and heart rate. The mean initial dose of captopril was 9.2 +/- 1.2 mg which was titrated to a mean daily dose of 40.7 +/- 3.3 mg given three-times daily. Each patient of group B received an initial dose of 2.5 mg enalapril and a mean maintenance dose of 8.4 +/- 0.9 mg once daily. The first dose effect on blood pressure was similar with captopril and enalapril with a maximal decrease of systolic and diastolic blood pressure of 8/8 mmHg (after 1 h) in group A and of 9/7 mmHg (after 4 h) in group B. The 24-h blood pressure values on day 5 were consistently below the pretreatment values (p less than 0.005) but heart rate was not significantly affected by either ACE-inhibitor. Neither group differed significantly during ACE-inhibition in their 24-h blood pressure and heart rate profiles.(ABSTRACT TRUNCATED AT 250 WORDS)